Telomir Pharmaceuticals, Inc. (TELO) Ratios
Telomir Pharmaceuticals, Inc. Ratios
TELO's free cash flow for Q2 2026 was $-1.01M. For the 2026 fiscal year, TELO's free cash flow was increased by $0.00 and operating cash flow was $-1.01M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.14 | 1.94 | 0.33 | 0.05 | 0.00 |
| Quick Ratio | 5.14 | 1.94 | 0.33 | 0.05 | 0.00 |
| Cash Ratio | 5.10 | 1.86 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -7.29 | -6.30 | -9.79 | 0.00 | 0.00 |
| Operating Cash Flow Ratio | -2.58 | -7.45 | -2.89 | -0.48 | -0.86 |
| Short-Term Operating Cash Flow Coverage | -7.79 | -54.27 | -38.22 | -0.81 | 0.00 |
| Net Current Asset Value | $ 5.91M | $ 643.04K | $ -900.34K | $ -937.28K | $ -138.13K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.07 | 0.02 | 11.94 | 0.00 |
| Debt-to-Equity Ratio | 0.08 | 0.15 | 0.03 | -0.62 | 0.00 |
| Debt-to-Capital Ratio | 0.07 | 0.13 | 0.03 | -1.64 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.24 | 2.06 | 1.39 | -0.05 | -0.66 |
| Debt Service Coverage Ratio | -21.98 | -0.01 | -6.55 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 2.82 | -2.40 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | -0.14 | 0.06 | 0.02 | 0.00 |
| Net Debt to EBITDA | 0.65 | -24.43 | -0.01 | 0.00 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.81% | 135.05% | 331.60% | 100.00% | 100.00% |
| Return on Assets (ROA) | -141.84% | -1248.69% | -273.83% | -1752.82% | -251.15% |
| Return on Equity (ROE) | -176.10% | -2571.04% | -380.19% | 91.13% | 166.16% |
| Return on Capital Employed (ROCE) | -178.22% | -1903.81% | -114.65% | 91.13% | 166.16% |
| Return on Invested Capital (ROIC) | -165.00% | -1662.28% | -111.38% | 240.27% | 166.16% |
| Return on Tangible Assets | -141.84% | -1248.69% | -273.83% | -1752.82% | -251.15% |
| Earnings Yield | -24.74% | -13.58% | -6.31% | -0.41% | -0.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.12 | -0.17 | -0.13 | -0.02 | -0.00 |
| Free Cash Flow Per Share | -0.12 | -0.17 | -0.13 | -0.02 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -964949.00 | 0.00 | -29849.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -964949.00 | 0.00 | -29849.00 |
| Operating Cash Flow Coverage Ratio | -7.79 | -54.27 | -38.22 | -0.81 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -8.76% | -4.17% | -1.86% | -0.23% | -0.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.03 | -7.36 | -15.86 | -242.66 | -1500.52 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 7.12 | 189.26 | 60.28 | -221.14 | -2493.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.41 | -24.00 | -53.70 | -442.26 | -1735.92 |
| Price-to-Operating Cash Flow Ratio | -11.41 | -24.00 | -53.70 | -442.26 | -1735.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -0.27 | -0.01 | -0.47 | 0.00 |
| Enterprise Value Multiple | -3.39 | 2511.02 | -18.14 | 0.00 | 0.00 |
| Enterprise Value | 35.29M | 120.53M | 207.37M | 207.85M | 207.27M |
| EV to EBITDA | -3.39 | 2511.02 | -18.14 | 0.00 | 0.00 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -9.57 | -23.77 | -53.73 | -443.50 | -1735.92 |
| EV to Operating Cash Flow | -9.57 | -23.77 | -53.73 | -443.50 | -1735.98 |
| Tangible Book Value Per Share | 0.19 | 0.02 | 0.12 | -0.03 | -0.00 |
| Shareholders’ Equity Per Share | 0.19 | 0.02 | 0.12 | -0.03 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.33 | -0.56 | -0.44 | -0.03 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.36 | 1.14 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.35 | 0.31 | 0.30 | 0.55 | 0.86 |
Currency in USD
